34

T&L Co. Ltd

340570 · KQ · Healthcare / Medical Devices

25,900.00KRW+2900.00 (+12.61%)

Price History

Full chart

Market Stats

Previous Close23,000.00
Open23,100.00
Day Range23,000.00 – 26,800.00
52-Week Range21,071.94 – 35,800.00
Volume120.17K
Market Cap437.61B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield2.72%
Beta0.29
50-Day Avg29,601.00
200-Day Avg27,522.88

About

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Yoon-So Choi
  • Employees250
  • Headquarters767, Sinsu-ro, Yongin-si, South Korea, 16827, Korea
  • Websitehttps://www.tnl.co.kr

Leadership

  • Mr. Yoon-So ChoiChief Executive Officer · b. 1959

Financials

Income Statement

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue26.59B26.33B32.62B40.63B71.90B81.58B115.46B174.89B164.16B
Growth (%)--0.98%+23.90%+24.56%+76.94%+13.47%+41.54%+51.47%-6.14%
Cost of Revenue17.15B15.62B19.49B24.83B41.38B47.37B70.31B99.40B91.77B
Gross Profit9.44B10.71B13.14B15.81B30.51B34.21B45.15B75.49B72.39B
Gross Margin35.49%40.66%40.27%38.90%42.44%41.93%39.11%43.17%44.10%
Operating Expense3.69B5.43B5.47B6.22B8.19B9.90B14.31B18.54B26.04B
Operating Income5.75B5.27B7.67B9.59B22.33B24.31B30.84B56.96B46.35B
Operating Margin21.61%20.03%23.50%23.61%31.06%29.80%26.71%32.57%28.24%
EBITDA-----27.70B35.87B66.21B52.50B
EBITDA Margin-----33.95%31.06%37.86%31.98%
Net Income4.80B4.66B7.29B10.04B19.58B21.12B27.44B46.41B38.07B
Net Income Margin18.06%17.69%22.34%24.71%27.24%25.89%23.76%26.54%23.19%
R&D--1.79B1.96B2.27B2.47B3.43B3.25B4.57B
R&D as % of Total Revenue--5.50%4.83%3.16%3.03%2.97%1.86%2.78%
Interest Expense0067.53M28.35M3.90M33.50M7.47M87.74M13.43M
Interest Expense % of Total Revenue0.00%0.00%0.21%0.07%0.01%0.04%0.01%0.05%0.01%

Balance Sheet

Currency: KRW2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets33.57B36.53B43.32B79.45B98.31B117.00B142.11B197.08B217.08B
Total Liabilities9.81B9.29B10.09B7.50B8.22B10.92B12.55B25.64B15.92B
Total Equity23.76B27.24B33.23B71.95B90.09B106.07B129.55B171.44B201.16B
Cash3.45M6.15M5.15M34.63B3.08M2.21M19.27B60.71B73.69B
Total Debt5.33B3.35B2.71B18.34M-----

Cash Flow

Currency: KRW2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow6.39B7.83B9.34B19.01B15.41B32.59B46.57B37.69B
Investing Cash Flow-2.95B-3.77B-24.66B-15.32B-5.99B-30.10B-661.99M-
Financing Cash Flow-2.63B-1.92B25.26B-1.80B-5.14B-3.69B-4.58B-
Capital Expenditure2.81B4.28B2.98B16.02B16.01B14.90B16.41B18.09B
Free Cash Flow-4.11B5.90B2.99B-597.92M17.69B30.16B19.60B
Dividends Paid-1.28B1.28B1.63B3.25B3.63B4.44B6.05B
FCF to OCF-52.43%63.19%15.73%-3.88%54.28%64.76%52.01%
Dividend Paid to FCF-31.17%21.68%54.36%-543.75%20.53%14.72%30.88%

Earnings

Report DateApr 29, 2021Jul 25, 2021Oct 27, 2021Feb 9, 2022May 13, 2022Jul 26, 2022Nov 10, 2022Mar 21, 2023Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 26, 2024Mar 31, 2024Jun 30, 2024Sep 30, 2024Mar 26, 2025Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------------
EPS Actual431.50618.84758.03601.08516.00879.00677.00528.86486.79621.68473.88234.54439.751072.85820.361083.28981.95485.24702.07190.551025.381244.32
Surprise----------------------
TimingAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-market---Pre-market---Pre-market------

Key Statistics & Ratios

Market Cap437.61B
Enterprise Value353.18B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.50
Price / Book2.03
Revenue (TTM)175.16B
Gross Profit (TTM)83.72B
EBITDA64.23B
Profit Margin28.99%
Operating Margin44.56%
Return on Equity24.59%
Return on Assets16.08%
Shares Outstanding15.88M
Shares Float9.06M
Beta0.29
Dividend Yield2.72%
Dividend Rate750.00
Payout Ratio23.72%

Dividends

20251×
750.00Dec 29, 2025
20241×
375.00Dec 27, 2024
20231×
275.00Dec 27, 2023
20221×
225.00Dec 28, 2022
20211×
200.00Dec 29, 2021
20201×
100.00Dec 29, 2020

Stock Splits

  • Aug 6, 20262:1
  • Jul 5, 20212:1